Documents & Downloads

LLVK

IκB Phosphorylation Inhibitor

LLVK is a selective inhibitor of IκB phosphorylation, effectively suppressing the activation of pro-inflammatory pathways. It has been shown to reduce lipopolysaccharide (LPS)-induced production of cytokines such as IL-1β, IL-6, and TNF-α. LLVK holds potential as a valuable reagent for research focusing on inflammatory bowel disease, rheumatoid arthritis, and other conditions characterized by dysregulated inflammatory responses.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	798540-36-0
Applications	IκB Phosphorylation Inhibitor
Formula	C₂₃H₄₅N₅O₅
Molecular Weight	471.63
SMILES	[C@H](C(N[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)[C@H](C)C)=O)(NC([C@H](CC(C)C)N)=O)CC(C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.